urinary retention - Nursing Case Study
Pathophysiology
• Primary mechanism: Obstruction in the urinary tract, such as an enlarged prostate or urethral stricture, prevents urine from exiting the bladder, leading to urinary retention.
• Secondary mechanism: Impaired bladder muscle function, due to nerve damage or medications that affect muscle control, can reduce the bladder's ability to contract and expel urine effectively.
• Key complication: Prolonged urinary retention can lead to increased bladder pressure, potentially causing kidney damage and recurrent urinary tract infections (UTIs).
Patient Profile
Demographics:
67-year-old male, retired school teacher
History:
• Key past medical history: Benign prostatic hyperplasia (BPH)
• Current medications: Tamsulosin 0.4 mg daily
• Allergies: No known drug allergies
Current Presentation:
• Chief complaint: Difficulty urinating
• Key symptoms: Weak urine stream, frequent urge to urinate, sensation of incomplete bladder emptying
• Vital signs: Blood pressure 128/78 mmHg, Heart rate 72 bpm, Respiratory rate 16 breaths per minute, Temperature 98.6°F
Section 1
Initial assessment findings reveal that the patient exhibits a distended abdomen due to bladder fullness, which is palpable on physical examination. The bladder scan shows a residual urine volume of approximately 350 mL, indicating significant retention. The patient reports discomfort and a sensation of pressure in the lower abdomen. His urinalysis is pending, but the preliminary dipstick test reveals trace amounts of blood and leukocytes, suggesting possible irritation or infection.
The patient's neurological assessment is unremarkable, with no signs of peripheral neuropathy or neurological deficits. His gait is steady, and he has no history of falls or balance issues. The prostate exam confirms an enlarged, smooth, and firm prostate, consistent with benign prostatic hyperplasia. Despite taking Tamsulosin, the patient reports that his symptoms have progressively worsened over the past few weeks, prompting this visit to the clinic.
These findings suggest a need to adjust the current management plan to address the urinary retention more effectively. The nursing team discusses potential interventions such as catheterization to relieve the immediate discomfort and further evaluate the cause of urinary retention. Additionally, consideration is given to consulting the healthcare provider about optimizing medication or exploring alternative treatments for BPH. The focus remains on preventing complications such as recurrent UTIs and minimizing the impact on the patient's quality of life.
Section 2
Following the initial assessment and preliminary management, the nursing team proceeds with catheterization to immediately relieve the patient's discomfort from urinary retention. A straight catheter is inserted successfully, and approximately 400 mL of clear, yellow urine is drained from the bladder. The patient reports significant relief from the abdominal pressure and discomfort that he was experiencing. Vital signs remain stable post-procedure, with a blood pressure of 124/78 mmHg, heart rate of 76 beats per minute, and temperature of 98.6°F. The patient is observed for any signs of distress or complications following catheterization, such as hematuria or infection, but none are present.
The urinalysis results return, confirming the presence of mild hematuria and leukocytes, but no bacteria, suggesting irritation potentially due to the enlarged prostate rather than a full-blown urinary tract infection. Based on these findings, the nursing team consults with the healthcare provider, who suggests a follow-up appointment to discuss potentially adjusting the patient's medication regimen. This may include considering a combination therapy with a 5-alpha-reductase inhibitor to complement the Tamsulosin, aiming to reduce the prostate size over time and improve urinary flow.
The nursing care plan emphasizes patient education, ensuring the patient understands the importance of medication adherence and monitoring for any signs of urinary tract infection or worsening symptoms. The patient expresses understanding and is encouraged to maintain adequate hydration while avoiding bladder irritants such as caffeine and alcohol. The team schedules a follow-up visit in two weeks to reassess the patient's symptoms and evaluate the effectiveness of the adjusted treatment approach. This ongoing monitoring will help prevent complications and promote the patient's quality of life as they manage their condition.
Section 3
Two weeks later, the patient returns for his follow-up appointment. During the initial assessment, the nursing team notes that the patient appears in good spirits and reports a notable improvement in urinary symptoms since starting the combination therapy with Tamsulosin and a 5-alpha-reductase inhibitor. He mentions experiencing less urgency and frequency, and he is now able to void with greater ease. The patient adheres to the advice given regarding hydration and has been mindful to reduce caffeine and alcohol intake. His vital signs remain stable, with a blood pressure of 122/76 mmHg, heart rate of 74 beats per minute, and temperature of 98.4°F.
A repeat urinalysis is conducted, revealing a decrease in leukocytes and the absence of hematuria, which indicates reduced irritation and inflammation. The patient is pleased with the progress, and the healthcare provider confirms that the current medication regimen will be continued. The nurse reinforces the importance of ongoing medication adherence and monitoring for any new or worsening symptoms, such as difficulty urinating, pain, or signs of infection. The patient is advised to continue with lifestyle modifications and is scheduled for another follow-up in a month to ensure continued progress and reevaluate his condition.
The nursing team remains vigilant for any potential complications, such as urinary tract infections or medication side effects, and encourages the patient to contact the clinic if he experiences any concerning symptoms. This proactive management aims to maintain the patient's quality of life and prevent any future episodes of urinary retention, ensuring a comprehensive and patient-centered approach to care.
Section 4
Three weeks after the follow-up appointment, the patient experiences a minor setback, prompting an unscheduled visit to the clinic. The patient reports a slight increase in urinary frequency and a sensation of incomplete bladder emptying over the past few days. Despite these symptoms, he denies any pain or burning sensation during urination, and there is no fever present. His vital signs remain stable, with a blood pressure of 118/72 mmHg, heart rate of 76 beats per minute, and a temperature of 98.1°F.
A focused assessment reveals mild suprapubic tenderness, and a bladder scan indicates a post-void residual volume greater than his previous measurements, suggesting incomplete bladder emptying. A repeat urinalysis is ordered and shows a slight increase in leukocytes, although still within the normal range, and no presence of nitrites or hematuria. These findings suggest a potential early-stage complication, possibly related to mild bladder irritation or incomplete response to therapy.
The nursing team collaborates with the healthcare provider to adjust the patient's treatment plan. The provider recommends increasing the dose of Tamsulosin temporarily to enhance muscle relaxation in the prostate and bladder neck, facilitating improved urine flow. The nurse educates the patient on the importance of closely monitoring his symptoms and encourages increased hydration and avoidance of bladder irritants. The patient is advised to keep a urinary diary to track any changes in symptoms and is scheduled for a follow-up visit in two weeks to reassess his condition and ensure the adjusted treatment is effective.
Section 5
Two weeks later, the patient returns to the clinic for his scheduled follow-up visit. During the initial assessment, the nurse notes that the patient reports a noticeable improvement in his urinary symptoms. He states that the sensation of incomplete bladder emptying has diminished, and his urinary frequency has decreased slightly. The patient mentions that he has been diligent in maintaining his urinary diary, which reflects fewer nocturnal awakenings to void and a gradual return toward his baseline pattern of urination. He also reports that he has been adhering to the increased hydration recommendations and avoiding known bladder irritants such as caffeine and alcohol.
The nursing assessment reveals stable vital signs, with a blood pressure of 116/70 mmHg, a heart rate of 74 beats per minute, and a temperature of 98.2°F. Upon conducting a bladder scan, the post-void residual volume shows a slight decrease compared to the previous reading, indicating an improvement in bladder emptying. Additionally, a repeat urinalysis displays a further reduction in leukocytes, now well within the normal range, confirming the absence of significant bladder irritation or infection.
Given these positive changes, the healthcare provider decides to maintain the adjusted dose of Tamsulosin for another month, with a plan to gradually taper to the original dose as symptoms continue to improve. The nurse reinforces the importance of ongoing symptom monitoring and adherence to lifestyle modifications. The patient is encouraged to continue documenting any urinary symptoms in his diary and to return to the clinic sooner if any new or worsening symptoms occur. The plan includes another follow-up appointment in four weeks to reassess the intervention's effectiveness and ensure continued progress in managing his urinary retention.